Skip to content

To study the effects of kamsaharitaki avaleha prepared by two different methods in patients of Tamaka Shwasa (Bronchial Asthma)

Pharmaceutical standardization of kamsaharitaki avaleha & its granules and its effect on Tamaka Shwasa (Bronchial Asthma)

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/11/004167
Enrollment
60
Registered
2013-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from Tamaka Shwasa

Interventions

Intervention1: In Group A kamsaharitaki avaleha In Group B kamsaharitaki granules: In Group A kamsaharitaki avaleha 12 g BD with Lukewarm water after meal for 28 days In Group B kamsaharitaki granule

Sponsors

Institute for Post Graduate Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Patients presenting with classical signs and symptoms of Tamaka Shwasa, •Both the sexes having age between 16 years to 60 years •Mild persistent cases of Bronchial Asthma with daytime symptoms 3-6/week and nocturnal symptoms with 3-4/month. •Moderate persistence cases with daytime symptoms daily and nocturnal symptoms with one or more than one week but not more than 2 weeks.

Exclusion criteria

Exclusion criteria: Known patients of diabetes, Dyspnoea resulting from cardiac origin, anaemia, •Age above 60 years and below 16 years, •Patients suffering from tuberculosis, malignancy and other chronic debilitating diseases, HIV positive cases, •Pregnant and lactating mothers and Patients who depend on regular use of inhalers, •Patients suffering with other types of Shwasa, i.e. Maha, Urdha, Chhinna Shwasa will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Improvement will be assessed on the basis of relief found in cardinal symptoms of diseaseProgress in the signs and symptoms based on the standard pattern will be applied before and after treatment.Timepoint: 28days

Secondary

MeasureTime frame
Improvement will be assessed on the basis of relief found in cardinal symptoms of diseaseProgress in the signs and symptoms based on the standard pattern will be applied before and after treatment.Timepoint: 28days

Countries

India

Contacts

Public ContactBJ PATGIRI

IPGTRA GAU Jamnagar

patgiri124@gmail.com9426947438

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026